LINC00942 has been reported as a tumor promoter in various cancers, including lung adenocarcinoma (Xi and Wang 2021), breast cancer (Sun et al. 2020), and gastric cancer (Zhu et al. 2022). Here, LINC00942 is linked to cancer.